Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hyperglycemia 2Lymphoma 1Insulin Resistance 1Hyperphagia 1Diabetes Mellitus, Type 2 1

Interventions

relacorilant 4Dipeptidyl-Peptidase IV Inhibitors 4Sulfonylurea Compounds 3Resistance Training 3Pioglitazone 3Metformin 3Sodium-Glucose Transporter 2 Inhibitors 2Rosiglitazone 2Nutritional Status 2Glucagon-Like Peptide-1 Receptor Agonists 2voglibose 1saxagliptin 1repaglinide 1pembrolizumab 1miglitol 1metahexamide 1meglitinide 1glymidine 1glisoxepide 1gliquidone 1glimepiride 1glibornuride 1empagliflozin 1desaminopancreozymin octapeptide 1Vildagliptin 1Troglitazone 1Tolbutamide 1Tolazamide 1Thiazolidinediones 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diabetes Mellitus, Type 2 × Insulin Glargine × Clear all
NCT02012465 2018-05-07

Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
15 enrolled
Lymphoid

Diabetes Mellitus, Type 2, Hyperglycemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡